NEOGENOMICS

Serial Number 98294074
Registration 7727408
700

Registration Progress

Application Filed
Dec 1, 2023
Under Examination
Approved for Publication
Jan 28, 2025
Published for Opposition
Jan 28, 2025
Registered
Mar 18, 2025

Trademark Image

NEOGENOMICS

Basic Information

Serial Number
98294074
Registration Number
7727408
Filing Date
December 1, 2023
Registration Date
March 18, 2025
Published for Opposition
January 28, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 18, 2025
Registration
Registered
Classes
005 041 042 044

Rights Holder

NeoGenomics Laboratories, Inc.

03
Address
9490 NeoGenomics Way
Fort Myers, FL 33912

Ownership History

NeoGenomics Laboratories, Inc.

Original Applicant
03
Fort Myers, FL

NeoGenomics Laboratories, Inc.

Owner at Publication
03
Fort Myers, FL

NeoGenomics Laboratories, Inc.

Original Registrant
03
Fort Myers, FL

Legal Representation

Attorney
Anessa O. Kramer

USPTO Deadlines

Next Deadline
2075 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-18)
Due Date
March 18, 2031
Grace Period Ends
September 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description
Mar 18, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 18, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jan 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 6, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 26, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2024 GNFR O FINAL REFUSAL E-MAILED
Sep 30, 2024 CNFR R FINAL REFUSAL WRITTEN
Sep 30, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 29, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2024 CNRT R NON-FINAL ACTION WRITTEN
Jun 3, 2024 GNRT F NON-FINAL ACTION E-MAILED
May 31, 2024 DOCK D ASSIGNED TO EXAMINER
Feb 25, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 1, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Medical tests kits primarily comprised of medical diagnostic reagents and assays for testing body fluids
First Use Anywhere: Jan 1, 2021
First Use in Commerce: Jan 1, 2021
Class 041
Education services, namely, providing training and on-demand on-line training in the form of courses, seminars and workshops in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; Education services, namely, providing non-downloadable webinars in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions
First Use Anywhere: Jan 1, 2021
First Use in Commerce: Jan 1, 2021
Class 042
Scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for medical research and medical diagnostic purposes in the field of human disease and human medical conditions; medical research laboratory services; oncology reference medical research laboratories; providing medical research information, interactive medical research information; and preparing and providing reports to others summarizing and analyzing results of scientific testing and research in the field of pathology, diagnostic testing, oncology testing
First Use Anywhere: Jan 1, 2021
First Use in Commerce: Jan 1, 2021
Class 044
Medical diagnostic testing services in the field of human disease and human medical conditions; medical analysis services for diagnostics and testing purposes provided by medical laboratories; medical analysis services for diagnostics and testing purposes provided by oncology medical laboratories
First Use Anywhere: Jan 1, 2021
First Use in Commerce: Jan 1, 2021

Additional Information

Design Mark
The mark consists of two curved lines overlapping each other. To the right of the two curved lines overlapping each other is the bold capital letters "NEO". Directly beneath the bold capital letters "NEO" are smaller capital letters that spell "GENOMICS".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 041 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
GENOMICS